These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23948883)

  • 21. Apolipoprotein ɛ4 Allele and Dental Occlusion Deficiency as Risk Factors for Alzheimer's Disease.
    Popovac A; Mladenović I; Krunić J; Trifković B; Todorović A; Milašin J; Despotović N; Stančić I
    J Alzheimers Dis; 2020; 74(3):797-802. PubMed ID: 32116259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocytes from young healthy persons carrying the ApoE4 allele overexpress stress-related proteins involved in the pathophysiology of Alzheimer's disease.
    Badia MC; Lloret A; Giraldo E; Dasí F; Olaso G; Alonso MD; Viña J
    J Alzheimers Dis; 2013; 33(1):77-83. PubMed ID: 22914590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
    Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.
    Sun X; Chiu CC; Liebson E; Crivello NA; Wang L; Claunch J; Folstein M; Rosenberg I; Mwamburi DM; Peter I; Qiu WQ
    Alzheimer Dis Assoc Disord; 2009; 23(3):238-44. PubMed ID: 19812466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction.
    Sutovsky S; Petrovic R; Fischerova M; Haverlikova V; Ukropcova B; Ukropec J; Turcani P
    J Alzheimers Dis; 2020; 77(3):1095-1105. PubMed ID: 32804129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.
    Romano RR; Carter MA; Dietrich MS; Cowan RL; Bruehl SP; Monroe TB
    J Alzheimers Dis; 2021; 79(3):1227-1233. PubMed ID: 33337380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
    Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
    Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.
    Dupuy AM; Mas E; Ritchie K; Descomps B; Badiou S; Cristol JP; Touchon J
    Gerontology; 2001; 47(4):213-8. PubMed ID: 11408727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PKR Inhibition Rescues Memory Deficit and ATF4 Overexpression in ApoE ε4 Human Replacement Mice.
    Segev Y; Barrera I; Ounallah-Saad H; Wibrand K; Sporild I; Livne A; Rosenberg T; David O; Mints M; Bramham CR; Rosenblum K
    J Neurosci; 2015 Sep; 35(38):12986-93. PubMed ID: 26400930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
    Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma angiotensin-converting enzyme in Alzheimer's disease.
    Vardy ER; Rice PJ; Bowie PC; Holmes JD; Catto AJ; Hooper NM
    J Alzheimers Dis; 2009; 16(3):609-18. PubMed ID: 19276555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
    Chételat G; Fouquet M
    Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    Supasitthumrong T; Tunvirachaisakul C; Aniwattanapong D; Tangwongchai S; Chuchuen P; Tawankanjanachot I; Snabboon T; Hemrungrojn S; Carvalho AF; Maes M
    J Alzheimers Dis; 2019; 71(3):797-811. PubMed ID: 31424390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.
    Sweet RA; Kamboh MI; Wisniewski SR; Lopez OL; Klunk WE; Kaufer DI; DeKosky ST
    J Geriatr Psychiatry Neurol; 2002; 15(1):24-30. PubMed ID: 11936240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.
    Haasl RJ; Ahmadi MR; Meethal SV; Gleason CE; Johnson SC; Asthana S; Bowen RL; Atwood CS
    BMC Med Genet; 2008 Apr; 9():37. PubMed ID: 18439297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered small-world anatomical networks in Apolipoprotein-E4 (ApoE4) carriers using MRI.
    Goryawala M; Zhou Q; Duara R; Loewenstein D; Cabrerizo M; Barker W; Adjouadi M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2468-71. PubMed ID: 25570490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polygenic Risk Score Analysis of Alzheimer's Disease in Cases without APOE4 or APOE2 Alleles.
    Escott-Price V; Myers A; Huentelman M; Shoai M; Hardy J
    J Prev Alzheimers Dis; 2019; 6(1):16-19. PubMed ID: 30569081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.
    Halliday MR; Rege SV; Ma Q; Zhao Z; Miller CA; Winkler EA; Zlokovic BV
    J Cereb Blood Flow Metab; 2016 Jan; 36(1):216-27. PubMed ID: 25757756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.